Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1999
12/02/1999WO1999061579A2 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE
12/02/1999WO1999061472A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061470A1 Respiratory nitrate reductase alpha subunit
12/02/1999WO1999061469A2 Prostate growth-associated membrane proteins
12/02/1999WO1999061468A2 The induction of antibiotic peptides by lait (scd14) protein
12/02/1999WO1999061467A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999WO1999061464A1 Process of purifying angiogenesis inhibitors
12/02/1999WO1999061463A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999WO1999061462A1 Antisense modulation of cellular adhesion molecule expression and treatment of cellular adhesion molecule-associated diseases
12/02/1999WO1999061460A1 Rna channels in biological membranes
12/02/1999WO1999061459A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999WO1999061454A1 Silica-guanidiniumthiocyanate dna isolation using casein
12/02/1999WO1999061453A2 priA
12/02/1999WO1999061452A2 acpS
12/02/1999WO1999061399A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
12/02/1999WO1999061289A1 Reinforced beam assembly
12/02/1999WO1999061066A2 Convection-enhanced delivery of aav vectors
12/02/1999WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors
12/02/1999WO1999061052A2 Oral immunization with papillomavirus virus-like particles
12/02/1999WO1999061050A1 MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA)
12/02/1999WO1999061049A2 Model for infection by a pathogen using administration of nucleic acids
12/02/1999WO1999061046A1 Parasite antigens
12/02/1999WO1999061043A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999WO1999061041A1 Novel peptides
12/02/1999WO1999061034A1 Improved vectors
12/02/1999WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999WO1999060843A1 Transgenic plants producing a pap ii protein
12/02/1999WO1999060842A2 Plant retroelements and methods related thereto
12/02/1999WO1999060838A1 Organism and method for metal recovery, remediation and separation
12/02/1999WO1999055564A8 Materials and methods for gene therapy
12/02/1999WO1999054477A3 Genetically engineered yeast and mutants thereof for the efficient fermentation of lignocellulose hydrolysates
12/02/1999WO1999053082A3 Hexose carrier proteins
12/02/1999WO1999053041A3 Method for increasing vitamin c content of plants
12/02/1999WO1999053017A3 Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene
12/02/1999WO1999052548A3 Conjugate vaccines for the prevention of dental caries
12/02/1999WO1999051774A3 A method for obtaining a plant with a genetic lesion in a gene sequence
12/02/1999WO1999051745A3 Dna immunization against chlamydia infection
12/02/1999WO1999050448A3 Nucleic acid detection method
12/02/1999WO1999050425A3 Regulated apoptosis using chemically induced dimerization of apoptosis factors
12/02/1999WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999WO1999050281A3 Collagen peptides and uses thereof
12/02/1999WO1999046381A9 Human fgf gene and gene expression products
12/02/1999WO1999046047A3 Detection and characterization of microorganisms
12/02/1999WO1999044063B1 Tumor tissue microarrays for rapid molecular profiling
12/02/1999WO1999043703A8 Method for immunochemically assaying anti-hm1.24 antibody
12/02/1999WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
12/02/1999WO1999035262A3 Apoptosis inducing molecule ii
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999WO1999023238A8 Efficient construction of vectors for gene targeting using phage-plasmid recombination
12/02/1999WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
12/02/1999DE19823834A1 Genetisches Verfahren zur Herstellung von Riboflavin Genetic procedure for the preparation of riboflavin
12/02/1999DE19823216A1 A process for the overexpression and secretion of heterologous proteins
12/02/1999DE19531783C2 Verfahren zur Erhöhung der pflanzlichen Samenproduktion und zur Beschleunigung des Pflanzenwachstums durch zusätzliche plastidäre Pyruvat, Phosphat Dikinase A method for increasing plant seed production and for accelerating the growth of plants by additional plastidic pyruvate phosphate dikinase
12/02/1999CA2745939A1 Mara family helix-turn-helix domains and their methods of use
12/02/1999CA2745131A1 Aav5 vector and uses thereof
12/02/1999CA2726139A1 Polyhdroxyalkanoate biopolymer compositions
12/02/1999CA2343317A1 Novel peptides
12/02/1999CA2338344A1 Hematopoietic progenitor cell gene transduction
12/02/1999CA2334940A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999CA2333872A1 Mechanical lock with a cam-driven locking pawl
12/02/1999CA2333667A1 Murd protein and gene of pseudomonas aeruginosa
12/02/1999CA2333281A1 Carotenoid ketolase genes and gene products, production of ketocarotenoids and methods of modifying carotenoids using the genes
12/02/1999CA2333159A1 Method
12/02/1999CA2333006A1 Calmodulin related protein
12/02/1999CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999CA2331833A1 Parasite antigens
12/02/1999CA2331553A1 Primers for the detection of spore forming bacteria in paper products and paper manufacturing streams
12/02/1999CA2331456A1 Reinforced beam assembly
12/02/1999CA2329694A1 Kunitz domain polypeptide and materials and methods for making it
12/02/1999CA2329525A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods
12/02/1999CA2329515A1 Silica-guanidiniumthiocyanate dna isolation using casein
12/02/1999CA2329513A1 System for reproducing and modulating stability and turnover of rna molecules
12/02/1999CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999CA2329505A1 Recombinant aav vectors for gene therapy of hemophilia a
12/02/1999CA2329274A1 Interleukin-21
12/02/1999CA2329269A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999CA2329246A1 Method for the isolation of ccc plasmid dna
12/02/1999CA2329159A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products
12/02/1999CA2329157A1 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999CA2329156A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
12/02/1999CA2329155A1 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
12/02/1999CA2329150A1 Transgenic plants producing a pap ii protein
12/02/1999CA2329143A1 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999CA2329140A1 Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy
12/02/1999CA2329136A1 Oral immunization with papillomavirus virus-like particles
12/02/1999CA2329131A1 Method for recovering soluble protein
12/02/1999CA2329124A1 Sphingosine kinase, cloning, expression and methods of use
12/02/1999CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2329057A1 Demonstrating resistance to antibiotics in microorganisms
12/02/1999CA2329056A1 Cell cycle genes, proteins and uses thereof
12/02/1999CA2329053A1 Human socs proteins
12/02/1999CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999CA2328905A1 Prostate growth-associated membrane proteins
12/02/1999CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999CA2328892A1 Tumor suppressor